Abstract:Transformed cells rely on both lipid internalization and the mobilization of intracellular lipid reservoirs, through several mechanisms such as de novo lipid biosynthesis, the mobilization of lipid droplets (LDs), and membrane remodeling. Additionally, lipid mediators, such as prostaglandin E2, cholesterol, and fatty acids derived from either the stroma or the tumor tissue, may facilitate the recruitment of non-malignant host cells, including immune cells and CAFs.Despite the complexity involved, these aspects underscore the necessity of a deeper understanding of the functions that the different lipid molecules and their metabolism play in cancer development, as well as in its progression and resistance to therapies.In this research topic "Lipid Alterations in Cancer Development, Resistance and Recurrence", the study of Gu X. et al. (Doi.org/10.3389/fcell.2022.883059) aimed to determine the effects of lipid metabolism on the progression and development of hepatocellular carcinoma (HCC). The authors used the expression profiles and clinical data of 371 and 231 patients with HCC obtained from the TCGA and Internal Cancer Genome Consortium (ICGC) databases, respectively. Through Cox and LASSO regression analyses, a prognostic risk model was constructed based on the lipid metabolism-associated genes (LMAG) data. The tumor mutation burden (TMB), immune cell infiltration levels, and immune response checkpoints of the identified risk groups were determined and compared. A total of two clusters were identified based on the LMAG expression, showing significant differences in tumor stage and immune cell infiltration. A prognostic risk model based on four LMAGs was constructed and proven to have a significant prognostic value. The 1-, 3-, and 5-year survival rates in the high-risk group were 62.2%, 20.5%, and 8.1%, respectively, whereas those in the low-risk group were 78.9%, 28.1%, and 13.5%, respectively. The survival differences between the two risk groups were likely associated with TP53 mutation status, TMB score, degree of immunocyte infiltration, and immune checkpoint level. Likewise, the expression level of every LMAG included in the model had the same effect on the overall survival and immune cell infiltration levels. More importantly, the prognostic value of the signature was verified in an independent ICGC cohort. Thus, the expression levels of LMAGs are closely related to the tumor microenvironment in HCC and may serve as promising biological indicators for prognosis and immune therapy in patients with HCC.Interestingly, the review written by Maurotti S. et al. (Doi.org/10.3389/fcell.2024.1404006) focuses on the role of the LDs in the hepatocarcinoma development. This is of particular importance because, contrary to what believed until some years ago, LDs are now considered a "metabolic hallmark" within many solid tumors like colon, prostate, breast, lung and even neurological tumors. In this review, the authors try to elucidate the LD function in all pre-tumoral stages, including Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic dysfunction-Associated Steatohepatitis (MASH), and fibrosis, which ultimately contribute to the actual development of the tumor. Some of the most important genetic alterations, as PNPLA3, TM6SF2, MBOAT7, SUGP1, MARC1, and GCKR, responsible for the different pathological liver stages are also examined. (CPTAC,n = 115) to explore the interplay between lipid metabolism and High Mobility Group Box 1 protein (HMGB1) in non-small cell lung cancer (NSCLC) tumors. Previous researches have indicated that unsaturated fatty acids can influence the expression of proteins that play a role in tumorigenesis. Here, the study is focused on specific proteins within the lipogenic and HMGB1/RAGE signaling pathways. The results demonstrated a correlation between stearoyl-CoA desaturase 1 (SCD1) and HMGB1 protein levels in NSCLC tumors. Additionally, in vitro experiments revealed that modulating SCD1 activity resulted in alterations in HMGB1 release, which was associated with changes in PD-L1 expression on the surfaces of lung cancer and innate immune cells. Preliminary analyses of select NSCLC patient samples indicated a potential association between serum HMGB1 levels and tumor-associated PD-L1 expression.In order to discover new strategies of treating cancer, it is necessary to develop a profound knowledge of the mechanisms through which disrupted lipid metabolism impacts the processes of cancer progression. It is clear that targeting a pathway or only a single-step of lipid metabolism will be probably insufficient in an attempt to develop more efficient cancer therapies. Combinatorial therapeutic approaches aimed at inhibiting tumor growth while enhancing the capacity of the immune system to target cancer cells seem to offer promising opportunities in the pharmacological research of lipid-based agents. However, there is cu -Abstract Truncated-

In Vitro Lipid Overload Affects Cellular Proliferation, Apoptosis, and Senescence in a Time-Dependent Manner in HepG2 Hepatocytes and LX-2 Hepatic Stellate Cells

Glucose Fluctuation Increased Hepatocyte Apoptosis under Lipotoxicity and the Involvement of Mitochondrial Permeability Transition Opening.

Hepatocyte Steatosis Increases the Expression of Adhesion Molecules in Endothelial Cells

Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease

Effect of Lipid on Proliferation and Activation of Rat Hepatic Stellate Cells (I)

An in vitro hepatic steatosis cell model for study of non-alcoholic fatty liver disease]

Tolerance of Repeated Toxic Injuries of Murine Livers is Associated with Steatosis and Inflammation

Long chain saturated and unsaturated fatty acids exert opposing effects on viability and function of GLP-1-producing cells: Mechanisms of lipotoxicity

Abstract 4449: Hepatic steatosis induced by bioactive lipids

LX-2 Stellate Cells Are a Model System for Investigating the Regulation of Hepatic Vitamin A Metabolism and Respond to Tumor Necrosis Factor α and Interleukin 1 β

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway

Extracellular vesicles originating from steatotic hepatocytes promote hepatic stellate cell senescence via AKT/mTOR signaling

The Impact of Liver Steatosis on Interleukin and Growth Factors Kinetics during Chronic Hepatitis C Treatment

Editorial: Lipid alterations in cancer development, resistance and recurrence

Effects of Kupffer Cells Stimulated by Triglyceride and Very Low-Density Lipoprotein on Proliferation of Rat Hepatic Stellate Cells.

Cholesterol Depletion Activate Hepatic Stellate Cells Mediated Through SREBP‐2 Signaling

Influence of simvastatin on hepatocytes - histopathological and immunohistochemical study

Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet

Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression

Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets